These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16961726

  • 1. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
    Gresele P, Momi S.
    Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
    [Abstract] [Full Text] [Related]

  • 2. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E.
    Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
    [Abstract] [Full Text] [Related]

  • 3. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
    Corazzi T, Leone M, Maucci R, Corazzi L, Gresele P.
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
    [Abstract] [Full Text] [Related]

  • 4. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL, McKnight W, Del Soldato P, Baydoun AR, Cirino G.
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [Abstract] [Full Text] [Related]

  • 5. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
    Fiorucci S, Mencarelli A, Meneguzzi A, Lechi A, Renga B, del Soldato P, Morelli A, Minuz P.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):635-41. PubMed ID: 15358033
    [Abstract] [Full Text] [Related]

  • 6. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
    Fiorucci S, Distrutti E, Mencarelli A, Rizzo G, Lorenzo AR, Baldoni M, Del Soldato P, Morelli A, Wallace JL.
    J Pharmacol Exp Ther; 2004 Jun 04; 309(3):1174-82. PubMed ID: 14762100
    [Abstract] [Full Text] [Related]

  • 7. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
    Rossoni G, Berti M, Colonna VD, Bernareggi M, Del Soldato P, Berti F.
    Ital Heart J; 2000 Feb 04; 1(2):146-55. PubMed ID: 10730616
    [Abstract] [Full Text] [Related]

  • 8. Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent.
    Gresele P, Marzotti S, Guglielmini G, Momi S, Giannini S, Minuz P, Lucidi P, Bolli GB.
    Diabetes Care; 2010 Jun 04; 33(6):1262-8. PubMed ID: 20299485
    [Abstract] [Full Text] [Related]

  • 9. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P.
    Thromb Haemost; 1996 Nov 04; 76(5):791-8. PubMed ID: 8950792
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia.
    Emanueli C, Van Linthout S, Salis MB, Monopoli A, Del Soldato P, Ongini E, Madeddu P.
    Arterioscler Thromb Vasc Biol; 2004 Nov 04; 24(11):2082-7. PubMed ID: 15345513
    [Abstract] [Full Text] [Related]

  • 11. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U, Schweeger-Exeli I, Marsik C, Cardona F, Minuz P, Jilma B.
    Platelets; 2010 Nov 04; 21(5):320-8. PubMed ID: 20608787
    [Abstract] [Full Text] [Related]

  • 12. Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.
    Kutala VK, Khan M, Mandal R, Potaraju V, Colantuono G, Kumbala D, Kuppusamy P.
    J Cardiovasc Pharmacol; 2006 Sep 04; 48(3):79-87. PubMed ID: 17031260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
    Takeuchi K, Ukawa H, Konaka A, Kitamura M, Sugawa Y.
    J Pharmacol Exp Ther; 1998 Jul 04; 286(1):115-21. PubMed ID: 9655849
    [Abstract] [Full Text] [Related]

  • 15. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.
    Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W.
    Int J Oncol; 2003 Jun 04; 22(6):1297-302. PubMed ID: 12738997
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
    Fiorucci S, Santucci L, Gresele P, Faccino RM, Del Soldato P, Morelli A.
    Gastroenterology; 2003 Mar 04; 124(3):600-7. PubMed ID: 12612897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester].
    Wallace JL, Muscará MN, de Nucci G, Zamuner S, Cirino G, del Soldato P, Ongini E.
    J Pharmacol Exp Ther; 2004 May 04; 309(2):626-33. PubMed ID: 14755007
    [Abstract] [Full Text] [Related]

  • 19. NCX-4016 NicOx.
    Di Napoli M, Papa F.
    Curr Opin Investig Drugs; 2003 Sep 04; 4(9):1126-39. PubMed ID: 14582459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.